(The TQCC of Hemoglobin is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA32
β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study14
Prevalence and Management of β-Thalassemia in India11
Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis10
Thalassemia in Thailand10
Association between Hb A1c and Severity of COVID-19 Patients10
Thalassemia in Pakistan9
Molecular Characterization of β- and α-Globin Gene Mutations in Individuals with Borderline Hb A2 Levels9
Thalassemia in Indonesia9
Hematological Characteristics of β-Globin Gene Mutation –50 (G>A) (HBB: c.-100G>A) Carriers in Mainland China9
Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation8
Hb Hezhou [β64(E8)Gly→Ser; HBB: c.193G>A]: A Novel Variant on the β-Globin Gene8
High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India8
Perforated Duodenal Ulcer Associated with Deferasirox in a Child with β-Thalassemia Major8
THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People’s Republic of China8
Hb Bart’s Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (– –CR) α0-Thalassemia in Two Unrelated Thai Families8
Thalassemia in Malaysia8
Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia8
Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica8
Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review7
Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies7
Quality of Life and Related Factors in β-Thalassemia Patients6
δ-Globin Chain Variants Associated with Decreased Hb A2 Levels: A National Reference Laboratory Experience6
Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India6
Evaluation of Erythroferrone, Hepcidin, and Iron Overload Status in Iraqi Transfusion-Dependent β-Thalassemia Major Patients6
Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh6
The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation6
The Prevalence of Hypothyroidism among Patients With β-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies5
Transcranial Doppler Velocities among Sickle Cell Disease Patients in Steady State5
Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali β-Thalassemia Major Children5
Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program5
A Novel α-Globin Chain Variant, Hb Nanchang [HBA2: c.46G>A, Codon 15 (GGT>AGT) (Gly→Ser)], Detected by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectr5
Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia5
Molecular Spectrum of β-Thalassemia Mutations in Central to Eastern Thailand5
Implications of Population Screening for Thalassemias and Hemoglobinopathies in Rural Areas of West Bengal, India: Report of a 10-Year Study of 287,258 Cases5
Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients5
COVID-19 and Anemia: What Do We Know So Far?5
Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions5
Detection of an α-Globin Fusion Gene Using Real-Time Polymerase Chain Reaction-Based Multicolor Melting Curve5
A Report on the Education, Employment and Marital Status of Thalassemia Patients from a Tertiary Care Center in the Middle East4
Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration4
Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease via Targeting of ATF44
Fifteen Cases of Hb J-Meerut: The Rare Association with Hb E and/or HBA1: c.-24C>G (or HBA2) Variants4
Pedigree Analysis of Nonhomologous Sequence Recombination of HBA1 and HBA2 Genes4
Molecular Genetic Analysis of α-Thalassemia in Hamadan Province, West Iran4
Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece4
Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing4
Spectrum of β-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0–15 Years3
Thalassemia in Viet Nam3
A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients3
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy3
Distribution of HBB Gene Mutations in the Kurdish Population of Ilam Province, West Iran3
Development of the Next Generation Sequencing-Based Diagnostic Test for β-Thalassemia and its Validation in a Pashtun Family3
Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve α- and β-Thalassemia Carrier Screening in Pregnant Women in Vietnam3
Compound Heterozygosity for a Novel Mutation Codon 104 (–A) (HBB: c.313delA) and Codons 41/42 (–CTTT) (HBB: c.126_129delCTTT) Leading to β-Thalassemia Major in a Chinese Family3
Calcium Channel Blockers in Conjunction with Standard Iron-Chelating Agents for β-Thalassemia Major: Systematic Literature Search3
Characterization of a Novel 71.8 kb α0-Thalassemia Deletion and Subsequent Summary of a Practical Procedure for Thalassemia Molecular Diagnosis3
Hb A2-Calderdale [δ2(NA2)His→Asn; HBD: c.7C>A] and Misdiagnosis of Type 2 Diabetes Mellitus Due to Interference with Hb A1c When Using Cation Exchange High Performance 3
Novel α0-Thalassemia Deletion Identified in an Indian Infant with Hb H Disease3
Pituitary Iron Deposition and Endocrine Complications in Patients with β-Thalassemia: From Childhood to Adulthood3
Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with β-Thalassemia Major from Three Different Graft Types3
Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital2
β-Globin Gene Mutations in Pediatric Patients with β-Thalassemia in the Region of Çukurova, Turkey2
Development of the Quality of Life Questionnaire (SF-36) for Patients with β-Thalassemia Major and β-Thalassemia Intermedia Based on Extended Rasch Analysis2
An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong2
Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient–Physician Partnerships to Improve Care2
Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with β-Thalassemia Major2
The Trend in Timing of Prenatal Diagnosis for Thalassemia at a Chinese Tertiary Obstetric Center2
A New Case of Hb Headington (HBB: c.217A>C) Due to a New DNA Transversion, Found in a Patient with Type 2 Diabetes Mellitus2
Thalassemia in India2
Heterozygosity for the Novel HBA2: c.*91_*92delTA Polyadenylation Site Variant on the α2-Globin Gene Expanding the Genetic Spectrum of α-Thalassemia in Iran2
Hb Manitoba [α102(G9)Ser→Arg] in Pasifika: Tongan Case Report2
An Autopsy Case of β-Thalassemia Major Illuminating the Pathological Spectrum of the Disease2
How I Treat Acute Chest Syndrome in Asthmatic Children with Sickle Cell Disease. A Practical Review2
Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece2
A Novel Hemoglobin Variant Hb Liaobu [α107(G14)Val→Leu, HBA2: c.322G>C] Detected by Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry2
The Effect of Five Single Nucleotide Polymorphisms on Hb F Variation of β-Thalassemia Traits and Hematologically Normal Individuals in Southeast Turkey2
A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C β 68(E12) Leu-Pro]: A First Report in the Chinese Population2
Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with α-Thalassemia and β-Globin Gene Cluster Haplotypes from Odisha, India2
Two Novel and Five Rare Mutations in the Non Coding Regions of the β-Globin Gene in the Iranian Population2
Inner Ear Complications in Children and Adolescents with Sickle Cell Disease2
Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor2
Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia2
Thalassemia in Sri Lanka2
Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam2
Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in β-Thalassemia Major Patients2
Evaluation of the High Resolution Melting Approach for Detection of β-Thalassemia Gene Mutations2
Hb F Levels in β-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the β-Globin Gene Cluster2
Hb Lepore-Hong Kong: First Report of a Novel δ/β-Globin Gene Fusion in a Chinese Family2
Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry2
The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades2
First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the β-Globin Gene in the Indian Population2
Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait2